Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06289192 · ClinicalTrials.gov registry record · Phase 4
Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community
A Phase 4 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT06289192: Completed Phase 4 study, sponsored by Johns Hopkins University.
NCT06289192 is a Phase 4 study that has completed, run by Johns Hopkins University. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06289192, a Phase 4 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on intervention acceptability and feasibility among individuals in public housing as well as feedback on use of shared decision making when referring for low-dose chest CT (LDCT). The investigators will conduct a feasibility pilot study of a virtual counselor plus community health worker intervention. With a sample of participants from public housing units (N=15), the investigators will collect data on feasibility of recruitment, intervention engagement and completion, and short-term smoking cessation outcomes. Individuals will be assessed at baseline, 1 month and 3 months. At the end of three months, the investigators will conduct follow up interviews with a subset of pilot participants to collect qualitative data on intervention acceptability. Based on this information, the investigators will make iterative improvements to the combined intervention.
Primary Outcome
Acceptability and Feasibility will be assessed by the number of participants who complete intervention and surveys
Interventions
- OTHER Community Health Worker
- DRUG Nicotine Replacement Product
- BEHAVIORAL C-Raven Virtual Tobacco Cessation Counseling
- OTHER Lung Cancer Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2024-08-27 |
| Phase | Phase 4 |
What the finished NCT06289192 record still lists
NCT06289192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Community Health Worker is the first listed.
NCT06289192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06289192 about?
NCT06289192 is a clinical study titled "Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community". To inform a future randomized trial of a virtual counselor led computer delivered intervention for tobacco cessation augmented with community health worker (CHW) support and navigation to lung cancer screening in low-income housing units in Baltimore, the investigators propose to collect data on int...
What is the current status of trial NCT06289192?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2024-04-30. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT06289192?
The interventions under investigation include: Community Health Worker (OTHER), Nicotine Replacement Product (DRUG), C-Raven Virtual Tobacco Cessation Counseling (BEHAVIORAL), Lung Cancer Screening (OTHER).
Who is sponsoring clinical trial NCT06289192?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06289192's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI